REED JOHN C — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

REED JOHN C has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $16.24M.

Profile

John C. Reed is an executive vice president at Johnson & Johnson, overseeing the Innovative Medicine division's research and development. He has played a significant role in advancing the company's focus on immunology, oncology, and neurology.

Board memberships

• Johnson & Johnson

Awards & honors

• Leadership in Innovative Medicine R&D
• Contributions to drug development in immunology and oncology
• Strategic restructuring of the drug division

Recent Transactions

Companies — Last 90 Days

• JOHNSON & JOHNSON (JNJ) — 1 filings, last 2026-05-04

Frequently Asked Questions

Who is REED JOHN C?

John C. Reed is an executive vice president at Johnson & Johnson, overseeing the Innovative Medicine division's research and development. He has played a significant role in advancing the company's focus on immunology, oncology, and neurology.…

How many SEC Form 4 filings has REED JOHN C submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has REED JOHN C been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 4 open-market sales ($16.24M) across all tracked filings.

Where can I see all of REED JOHN C's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week